Delivery Order SPE2DB20D1109-SPE2DB22FN68G
Award Date 2/25/22
Potential Completion Date 2/28/22
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,688.86 and a period of performance ending on January 22, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension medication in 180 ml doses to the Defense Logistics Agency (DLA). The contract, valued at $1,270.30, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 18, 2024. The contract has a completion date of June 20, 2024 and is a firm-fixed price delivery order. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 120 ml bottles to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 9, 2023, with a ceiling value of $2,345.10. The contract has a firm fixed price and is a delivery order with a completion date of March 10, 2023. The award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp. The fixed-price delivery order has a ceiling value of $1,640.44 and a completion date of January 26, 2023. The award was made on January 25, 2023, and there was no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor that serves as a key vendor for...
- This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 120 ml, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., and has a ceiling value of $1,865.62. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00, which serves as the...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, awarded to AmerisourceBergen Drug Corp, has a ceiling value of $1,344.99 and an ultimate completion date of August 22, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. This award is likely part of a larger Indefinite...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,419.60, was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a firm fixed-price delivery order contract with an ultimate completion date of October 28, 2024. The contract does not have a set-aside designation, indicating open...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension, valued at $1,477.70, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 180 ml, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 2, 2024, with a ceiling value of $4,436.80 and a completion date of December 3, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation,...
- This federal contract award is for the delivery of Quillivant XR 25 mg/5 ml suspension in 60 ml bottles. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,024.80 and runs through December 10, 2024. This is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. Amerisourcebergen Drug...